SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new record highs in Shanghai and upcoming Chinese export restrictions. This surge is further fueled by critical industrial demand from AI data centers and green energy, prompting community discussion of a potential "silver squeeze" and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is trending due to the FDA's recent approval of YARTEMLEA, its first-in-class treatment for transplant-associated thrombotic microangiopathy (TA-TMA), a life-threatening condition with no prior approved therapies. The community is actively discussing the stock's perceived undervaluation, potential for a short squeeze given high short interest, and the significant financial backing from its existing multi-billion dollar partnership with Novo Nordisk. Investors anticipate further clarity on drug pricing and commercial strategy, reinforcing conviction for a substantial long-term re-rating.

ProShares Trust - ProShares UltraShort Silver -2x Shares

ProShares UltraShort Silver

ProShares UltraShort Silver ($ZSL) is trending as traders aggressively position for a significant correction in silver, widely viewed as overextended after its recent strong rally. The community is actively debating the sustainability of silver's gains, with many utilizing this inverse ETF as a direct bearish bet or to hedge existing precious metal holdings against anticipated market shifts.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is currently trending as its dedicated "Wolfpack" community actively promotes the recently launched WolfSwap, a cross-chain swap aggregator focused on utility and decentralization. The community is heavily discussing the project's potential as a leading memecoin, often drawing comparisons to early Shiba Inu, and highlighting its consistent trending presence across platforms. Many believe Sailana is building something unique and urge others not to overlook its ongoing development and future innovations planned for 2026.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang (CPNG) is trending due to significant fallout from a major data breach, which has prompted a CEO resignation and ongoing government investigations, including police searches and potential large-scale lawsuits. Community sentiment reflects strong concern over the company's handling of the incident and its implications for consumer trust and business operations in South Korea, its primary market.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending following its recent earnings report, which showcased revenue growth and an emphasized focus on providing essential on-site power for the surging AI-driven data center market. The community is actively discussing the potential for major contract conversions from their extensive pipeline of megawatts, with many viewing the company's natural gas-fueled solutions as a timely answer to the energy demands of hyperscalers, distinguishing it from other fuel cell players. This narrative, coupled with efforts to scale manufacturing and improve financials, fuels optimism for its path toward future profitability despite past challenges.

Bitwise 10 Crypto Index ETF - Common Shares Of Beneficial Interest

Bitwise 10 Crypto Index Fund

Bitwise 10 Crypto Index Fund is actively discussed amid a polarized crypto market, with strong bearish voices predicting a prolonged "crypto winter" while bullish investors point to increasing institutional adoption and positive fund inflows into the sector. A significant talking point for BITW is its notable trading discount to Net Asset Value, which the community anticipates could narrow as the fund progresses with its regulatory efforts to convert to an Exchange Traded Product. This potential structural change creates an arbitrage opportunity, driving conversation among those monitoring the fund's correlation to Bitcoin and other major digital assets.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony (UAMY) is drawing significant attention as China tightens export controls on critical minerals, particularly antimony, which is vital for U.S. defense and industrial applications. The conversation centers on UAMY's strategic importance as a rare domestic antimony supplier with its North American smelters, fueling speculation about potential large government contracts and acquisition interest. Community sentiment is sharply divided between those anticipating a major uplift from its unique market position and others expressing concern over recent stock volatility and perceived management inaction.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

AVNT CRYPTO is currently a hot topic, largely fueled by its recent listing on Robinhood and deep integration with Coinbase's Base chain, where it's positioned as a key perpetual decentralized exchange. The community is actively discussing its potential for significant price appreciation, driven by perceived undervaluation against competitors and the introduction of features like an AI trading bot and staking. Despite some past volatility, there's strong sentiment that its Coinbase backing and tokenomics could propel it higher.

GraniteShares ETF Trust - GraniteShares 2x Long AMD Daily ETF

GraniteShares 2x Long AMD Daily ETF

AMDL is currently trending with a strong bullish sentiment, fueled by positive developments for its underlying asset, AMD. Recent news, including an export license for AI chips to China and a significant partnership with the US Department of Energy for supercomputers, is driving community expectations for substantial growth and increased market share in the AI and semiconductor space. Traders are actively accumulating AMDL, a 2x leveraged ETF, anticipating explosive gains as AMD is perceived to be on a trajectory towards becoming a trillion-dollar company despite market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Assenagon Asset Management S.A. Has $2 Million Holdings in Avidity Biosciences, Inc. $RNA

Assenagon Asset Management S.A. raised its position in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 157.0% during the 3rd quarter, according to its most recent filing with the Securities...

Avidity Biosciences (NASDAQ:RNA) Lowered to Hold Rating by Evercore ISI

Evercore ISI downgraded shares of Avidity Biosciences from a "strong-buy" rating to a "hold" rating in a research report on Thursday...

Mirador Capital Partners LP Purchases 22,666 Shares of Avidity Biosciences, Inc. $RNA

Mirador Capital Partners LP grew its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 54.8% in the 3rd quarter, according to the company in its most recent Form 13F...

Frazier Life Sciences Management L.P. Has $17.75 Million Stock Holdings in Avidity Biosciences, Inc. $RNA

Frazier Life Sciences Management L.P. boosted its holdings in shares of Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 19.0% during the second quarter, according to its most recent 13F...

Avidity Biosciences (NASDAQ:RNA) Reaches New 52-Week High - What's Next?

Avidity Biosciences (NASDAQ:RNA) Hits New 12-Month High - Here's Why...

EcoR1 Capital LLC Sells 57,576 Shares of Avidity Biosciences, Inc. $RNA

EcoR1 Capital LLC lowered its holdings in shares of Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 10.3% in the second quarter, according to its most recent disclosure with the SEC. The firm...

Norges Bank Makes New Investment in Avidity Biosciences, Inc. $RNA

Norges Bank purchased a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 995,118...

Franklin Resources Inc. Sells 29,465 Shares of Avidity Biosciences, Inc. $RNA

Franklin Resources Inc. lowered its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 44.0% in the 2nd quarter, according to its most recent Form 13F filing with the...

Avidity Biosciences (NASDAQ:RNA) Reaches New 52-Week High - Still a Buy?

Avidity Biosciences (NASDAQ:RNA) Sets New 1-Year High - Here's What Happened...

JPMorgan Chase & Co. Buys 139,473 Shares of Avidity Biosciences, Inc. $RNA

JPMorgan Chase & Co. lifted its stake in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 31.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange...

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

RNA
Avidity Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RNA News

RNAAvidity Biosciences Inc